Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Quality in acute inpatient rheumatology 2021 : Current aspects of the KOBRA quality label of the Association of Rheumatological Acute Care Clinics].

Zeitschrift fur Rheumatologie·2021
Same author

[Outpatient specialist medical treatment (ASV)-a new treatment level in rheumatology].

Zeitschrift fur Rheumatologie·2019
Same author

[Standards of care for people with rheumatoid arthritis in Europe : Translation and comments of the eumusc.net recommendations supported by EULAR performed by a national task force of the professional organisations DGRh and VRA supported by "Deutsche Rheumaliga"].

Zeitschrift fur Rheumatologie·2016
Same author

[International quality indicators in rheumatology. Suggestions for rheumatoid arthritis].

Zeitschrift fur Rheumatologie·2016
Same author

[Hospital financing in 2016. Relevant changes for rheumatology].

Zeitschrift fur Rheumatologie·2016
Same author

[Hospital financing in 2015. Relevant changes for rheumatology].

Zeitschrift fur Rheumatologie·2015
Same journal

[Prevention strategies in rheumatoid arthritis : From primary prevention to targeted drug interception].

Zeitschrift fur Rheumatologie·2026
Same journal

Methodological concerns and data discrepancies in the indirect treatment comparison of belimumab and anifrolumab.

Zeitschrift fur Rheumatologie·2026
Same journal

Evaluating the comparative efficacy of belimumab vs. anifrolumab in systemic lupus erythematosus: a response.

Zeitschrift fur Rheumatologie·2026
Same journal

[Update: DMARDs for MGUS].

Zeitschrift fur Rheumatologie·2026
Same journal

[A potpourri of diagnoses-Unusual manifestations of a chronic inflammatory bowel disease : Case report].

Zeitschrift fur Rheumatologie·2026
Same journal

[Not measurable but immeasurably important : Fever-The leading symptom of ancient medical theory].

Zeitschrift fur Rheumatologie·2026
See all related articles

Related Experiment Videos

[The G-DRG System 2009--relevant changes for rheumatology].

W Fiori1, A Liedtke-Dyong, H-J Lakomek

  • 1DRG-Research-Group, Medizinisches Management, Universitätsklinikum Münster, Domagkstr. 20, 48129 Münster, Deutschland. wolfgang.fiori@ukmuenster.de

Zeitschrift Fur Rheumatologie
|March 24, 2010
PubMed
Summary
This summary is machine-generated.

The 2010 G-DRG system changes impact hospital resource allocation. Hospitals must analyze economic effects, as rheumatology departments may see varied financial outcomes from these diagnosis and billing adjustments.

Related Experiment Videos

Area of Science:

  • Healthcare Economics
  • Medical Billing Systems
  • Health Information Management

Context:

  • The German Diagnosis Related Groups (G-DRG) system is a key tool for hospital resource redistribution.
  • The 2010 system updates involve significant changes to diagnosis and procedure classifications.
  • The billing process has also been revised for the 2010 implementation.

Purpose:

  • To outline the general and specific modifications within the G-DRG system for 2010.
  • To emphasize the necessity for hospitals to evaluate the economic implications of these G-DRG changes.
  • To consider the potential positive or negative financial consequences for rheumatology departments.

Summary:

  • The article details 2010 updates to the G-DRG system, including classification and billing process changes.
  • Hospitals are advised to use the G-DRG transition-grouper to assess economic impacts on their specific cases.
  • Potential financial effects on rheumatology departments are discussed in light of these adjustments.

Impact:

  • Hospitals can proactively manage financial strategies by understanding G-DRG system modifications.
  • Informed analysis allows for better resource allocation and departmental financial planning.
  • Consideration of case law provides a comprehensive understanding of the regulatory landscape affecting billing and reimbursement.